pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
aqualung-therapeutics PRESS RELEASE ARCHIVE
Dec 19, 2022
NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors Markets, 2040 with Profiles of Antengene Therapeutics, Aqualung Therapeutics, Karyopharm Therapeutics, OncoTartis, and Onxeo
Dec 5, 2019
Aqualung Therapeutics Corporation To Present New Data At Biotech Showcase Investor Conference
Aug 20, 2019
Aqualung Therapeutics Corporation Receives $225 Thousand Dollar National Institute of Health (NIH) Grant to Establish Biomarker Panel for Patients with Acute Respiratory Distress Syndrome
Jun 5, 2019
Aqualung Therapeutics Corporation Receives A $1.7 Million National Institute Of Health (NIH) Fastrack Award To Develop An Novel Immune-Based Therapeutic Antibody For Critically Ill Patients With Acute Lung Injury
